SXC Health Closes on $100M MedfusionRx Takeover

Pharmacy benefits manager SXC Health Solutions (NASDAQ:SXCI) has completed its $100 million purchase of MedfusionRx.

The price is subject to a customary working capital adjustment, with an additional $5.5 million subject to the achievement of certain performance targets through fiscal 2012, the Lisle, Ill-based company said on Wednesday.

The acquisition, announced earlier this month, is expected to help transform SXC’s specialty pharmacy business by expanding its presence and enhancing capabilities.

Founded in 2003 and based in Birmingham, Alabama, MedfusionRx, is a licensed, accredited specialty pharmacy provider with significant expertise in providing high-touch clinical services to patients with complex chronic conditions.